GSK

GSK’s ViiV Healthcare caps virtual HIV summit with a Facebook Live cabaret
Fierce Pharma
Sat, 11/14/20 - 09:56 pm
GSK
ViiV
HIV
Facebook
drug marketing
Tapping GSK tech, Medicago kickstarts later-stage COVID vax tests
Fierce Biotech
Thu, 11/12/20 - 10:42 am
GSK
Medicago
clinical trials
vaccines
COVID-19
GSK reports its long-acting HIV PrEP tops Gilead's Truvada — again
Endpoints
Mon, 11/9/20 - 11:56 am
GSK
ViiV
cabotegravir
HIV
PrEP
FDA
Bayer, ViiV and RB challenge limits of pharma marketing creativity with innovative thinking, executions and media
Fierce Pharma
Tue, 11/3/20 - 09:41 pm
Bayer
ViiV
Reckitt Benckiser
pharma marketing
GSK
digital marketing
DTC advertising
Sanofi, GSK pledge 200M doses to an international coronavirus vaccine alliance
BioPharma Dive
Wed, 10/28/20 - 12:19 pm
Sanofi
GSK
COVID-19
vaccines
COVAX
With FDA decision looming, GSK sweetens the PD-1 pot for discovery partner AnaptysBio as Hal Barron moves to guard his oncology strategy
Endpoints
Mon, 10/26/20 - 11:15 am
AnaptysBio
GSK
Tesaro
Zejula
GSK sees 'robust immune response' from RSV vaccine hopefuls
Fierce Pharma
Wed, 10/21/20 - 10:38 am
GSK
RSV
vaccines
clinical trials
GSK's Emma Walmsley granted damehood by Queen Elizabeth II
Endpoints
Tue, 10/13/20 - 10:03 pm
GSK
Pharma CEOs
Emma Walmsley
GSK, Vir cleared to leap into PhIII, angling for a spot in the Covid-19 antibody race led by Lilly, Regeneron
Endpoints
Tue, 10/6/20 - 10:38 am
GSK
Vir Biotechnology
COVID-19
clinical trials
Teva back on the hook for $235M to GSK for heart drug infringement
Fierce Pharma
Mon, 10/5/20 - 11:42 pm
Teva
GSK
Patent Infringement
Coreg
generics
patents
Nvidia to build the UK’s fastest supercomputer for AI drug-hunters at GSK, AstraZeneca and more
Fierce Biotech
Mon, 10/5/20 - 11:48 am
UK
NHS
GSK
AstraZeneca
supercomputer
artificial intelligence
drug discovery
NVIDIA
GSK's ViiV, armed with long-term Dovato data, eyes 'tipping point' for 2-drug HIV regimen
Fierce Pharma
Mon, 10/5/20 - 11:45 am
GSK
ViiV
Dovato
HIV
With a potential FDA approval looming, G1 Therapeutics taps ex-GSK US president Jack Bailey as new CEO
Endpoints
Thu, 10/1/20 - 11:04 pm
G1 Therapeutics
GSK
John Bailey
Mark Velleca
GlaxoSmithKline CEO Walmsley: COVID-19 is pharma's chance for redemption
Fierce Pharma
Wed, 09/30/20 - 10:44 pm
GSK
Pharma CEOs
Emma Walmsley
pandemic
COVID-19
Fourth-quarter events to watch for big pharma
EP Vantage
Mon, 09/28/20 - 10:34 pm
COVID-19
clinical trials
AstraZeneca
Gilead Sciences
Takeda
GSK
Roche
Alzheimer's disease
Bristol-Myers Squibb
Pfizer
Eli Lilly
GlaxoSmithKline's Nucala targets rival AstraZeneca with FDA nod for rare white blood cell disease
Fierce Pharma
Mon, 09/28/20 - 10:37 am
GSK
Nucala
hypereosinophilic syndrome
FDA
AstraZeneca
Drugmakers push forward on large-scale production of coronavirus vaccines
BioPharma Dive
Thu, 09/24/20 - 11:44 pm
vaccines
Operation Warp Speed
COVID-19
Pfizer
Moderna Therapeutics
AstraZeneca
Merck
JNJ
Novavax
GSK
Sanofi
Sanofi, GSK sign agreements with Government of Canada to supply 72 million doses of adjuvanted Covid-19 vaccine
Pharmaceutical Business Review
Wed, 09/23/20 - 10:44 am
COVID-19
vaccines
Canada
Sanofi
GSK
FDA approves Trelegy Ellipta as once-daily single inhaler triple therapy for asthma and COPD
Pharmaceutical Business Review
Thu, 09/10/20 - 10:52 am
GSK
Innovia
Trelegy Ellipta
COPD
asthma
FDA
COVID-19 vaccine CEOs vow to wait for phase 3 data before filing for approval
Fierce Pharma
Tue, 09/8/20 - 11:11 am
COVID-19
vaccines
Operation Warp Speed
Donald Trump
AstraZeneca
Pfizer
BioNTech
GSK
JNJ
Merck
Moderna Therapeutics
Novavax
Sanofi

Pages